Insider Buy/Sell Details for the Biotechnology Industry — January 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1179)
Relay Therapeutics, Inc. (RLAY)
Rahmer Peter — Chief Corporate Development Officer
Shares
1,354
Price
$8.45
Total Value
$11.44K
Shares Held After
276,610
% of Holdings
0.5%
Serina Therapeutics, Inc. (SER)
Moreadith Randall — Chief Scientific Officer
Shares
6,500
Price
$3.57
Total Value
$23.19K
Shares Held After
0
% of Holdings
100.0%
Anixa Biosciences, Inc. (ANIX)
Baskies Arnold M — Director
Shares
10,000
Price
$3.04
Total Value
$30.40K
Shares Held After
135,000
% of Holdings
7.4%
Acumen Pharmaceuticals, Inc. (ABOS)
Meisner Derek M — Chief Legal Officer & Corp Sec
Shares
2,671
Price
$3.00
Total Value
$8.02K
Shares Held After
173,999
% of Holdings
1.5%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
8,717
Price
$4.91
Total Value
$42.80K
Shares Held After
580,329
% of Holdings
1.5%
Celcuity Inc. (CELC)
Dalvey David — Director
Shares
20,000
Price
$120.03
Total Value
$2.40M
Shares Held After
90,000
% of Holdings
18.2%
NewAmsterdam Pharma Co N.V. (NAMS)
Kooij Louise Frederika — Chief Accounting Officer
Shares
39,816
Price
$32.62
Total Value
$1.30M
Shares Held After
24,353
% of Holdings
62.0%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
100
Price
$57.05
Total Value
$5.71K
Shares Held After
449,944
% of Holdings
0.0%
Relay Therapeutics, Inc. (RLAY)
Catinazzo Thomas — Chief Financial Officer
Shares
13,820
Price
$7.62
Total Value
$105.31K
Shares Held After
250,996
% of Holdings
5.2%
Relay Therapeutics, Inc. (RLAY)
Bergstrom Donald A — President, R&D
Shares
18,895
Price
$7.62
Total Value
$143.98K
Shares Held After
422,733
% of Holdings
4.3%
Relay Therapeutics, Inc. (RLAY)
Rahmer Peter — Chief Corporate Development Officer
Shares
11,684
Price
$7.62
Total Value
$89.03K
Shares Held After
277,964
% of Holdings
4.0%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
4,139
Price
$5.08
Total Value
$21.03K
Shares Held After
589,046
% of Holdings
0.7%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
51,865
Price
$30.10
Total Value
$1.56M
Shares Held After
419,173
% of Holdings
11.0%
Protagonist Therapeutics, Inc. (PTGX)
PATEL DINESH V PH D — Director
Shares
4,068
Price
$83.19
Total Value
$338.42K
Shares Held After
574,505
% of Holdings
0.7%
Protagonist Therapeutics, Inc. (PTGX)
Ali Asif — Chief Financial Officer
Shares
18,203
Price
$83.14
Total Value
$1.51M
Shares Held After
60,320
% of Holdings
23.2%
Protagonist Therapeutics, Inc. (PTGX)
Ali Asif — Chief Financial Officer
Shares
28,000
Price
$83.13
Total Value
$2.33M
Shares Held After
78,523
% of Holdings
26.3%
Protagonist Therapeutics, Inc. (PTGX)
MOLINA ARTURO MD — Chief Medical Officer
Shares
5,000
Price
$82.00
Total Value
$410.00K
Shares Held After
84,115
% of Holdings
5.6%
Kura Oncology, Inc. (KURA)
Powl Brian T. — Chief Commercial Officer
Shares
1,572
Price
$8.46
Total Value
$13.30K
Shares Held After
183,275
% of Holdings
0.9%
Kura Oncology, Inc. (KURA)
Powl Brian T. — Chief Commercial Officer
Shares
4,842
Price
$8.46
Total Value
$40.97K
Shares Held After
184,847
% of Holdings
2.6%
Kura Oncology, Inc. (KURA)
FORD KATHLEEN — Chief Operating Officer
Shares
1,813
Price
$8.46
Total Value
$15.34K
Shares Held After
153,560
% of Holdings
1.2%
Kura Oncology, Inc. (KURA)
Leoni Mollie — Chief Medical Officer
Shares
1,341
Price
$8.46
Total Value
$11.35K
Shares Held After
267,274
% of Holdings
0.5%
Kura Oncology, Inc. (KURA)
Leoni Mollie — Chief Medical Officer
Shares
951
Price
$8.46
Total Value
$8.05K
Shares Held After
268,615
% of Holdings
0.4%
Kura Oncology, Inc. (KURA)
Leoni Mollie — Chief Medical Officer
Shares
2,233
Price
$8.46
Total Value
$18.89K
Shares Held After
269,566
% of Holdings
0.8%
Kura Oncology, Inc. (KURA)
Leoni Mollie — Chief Medical Officer
Shares
3,655
Price
$8.46
Total Value
$30.92K
Shares Held After
271,799
% of Holdings
1.3%
Kura Oncology, Inc. (KURA)
DOYLE THOMAS JAMES — SVP, Finance & Accounting
Shares
881
Price
$8.46
Total Value
$7.45K
Shares Held After
145,167
% of Holdings
0.6%
Kura Oncology, Inc. (KURA)
DOYLE THOMAS JAMES — SVP, Finance & Accounting
Shares
2,226
Price
$8.46
Total Value
$18.83K
Shares Held After
146,048
% of Holdings
1.5%
Kura Oncology, Inc. (KURA)
DOYLE THOMAS JAMES — SVP, Finance & Accounting
Shares
695
Price
$8.46
Total Value
$5.88K
Shares Held After
148,274
% of Holdings
0.5%
Kura Oncology, Inc. (KURA)
DOYLE THOMAS JAMES — SVP, Finance & Accounting
Shares
1,114
Price
$8.46
Total Value
$9.43K
Shares Held After
148,969
% of Holdings
0.7%
Kura Oncology, Inc. (KURA)
DOYLE THOMAS JAMES — SVP, Finance & Accounting
Shares
2,226
Price
$8.46
Total Value
$18.83K
Shares Held After
150,083
% of Holdings
1.5%
Kura Oncology, Inc. (KURA)
Burrows Francis — Chief Scientific Officer
Shares
1,311
Price
$8.46
Total Value
$11.09K
Shares Held After
32,424
% of Holdings
3.9%
Kura Oncology, Inc. (KURA)
Bair Teresa Brophy — Chief Legal Officer
Shares
4,777
Price
$8.46
Total Value
$40.42K
Shares Held After
226,931
% of Holdings
2.1%
Kura Oncology, Inc. (KURA)
Bair Teresa Brophy — Chief Legal Officer
Shares
2,335
Price
$8.46
Total Value
$19.76K
Shares Held After
231,708
% of Holdings
1.0%
Kura Oncology, Inc. (KURA)
Bair Teresa Brophy — Chief Legal Officer
Shares
4,096
Price
$8.46
Total Value
$34.66K
Shares Held After
234,043
% of Holdings
1.7%
Acumen Pharmaceuticals, Inc. (ABOS)
Meisner Derek M — Chief Legal Officer & Corp Sec
Shares
15,085
Price
$3.00
Total Value
$45.26K
Shares Held After
173,999
% of Holdings
8.0%
Harmony Biosciences Holdings, Inc. (HRMY)
Kapadia Sandip — CHIEF FINANCIAL OFFICER
Shares
3,746
Price
$37.15
Total Value
$139.17K
Shares Held After
24,521
% of Holdings
13.3%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
7,875
Price
$471.91
Total Value
$3.72M
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
14,625
Price
$471.91
Total Value
$6.90M
Shares Held After
0
% of Holdings
100.0%
Liquidia Corp (LQDA)
Boyle Dana — Chief Accounting Officer
Shares
1,580
Price
$41.65
Total Value
$65.81K
Shares Held After
178,848
% of Holdings
0.9%
Liquidia Corp (LQDA)
Adair Jason — Chief Business Officer
Shares
688
Price
$41.65
Total Value
$28.66K
Shares Held After
211,169
% of Holdings
0.3%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
6,418
Price
$5.02
Total Value
$32.22K
Shares Held After
593,185
% of Holdings
1.1%
Milestone Pharmaceuticals Inc. (MIST)
Bharucha David — Chief Medical Officer
Shares
12,245
Price
$1.93
Total Value
$23.63K
Shares Held After
113,181
% of Holdings
9.8%
Milestone Pharmaceuticals Inc. (MIST)
Nelson Jeffrey Edward — Chief Operating Officer
Shares
12,245
Price
$1.93
Total Value
$23.63K
Shares Held After
49,848
% of Holdings
19.7%
Milestone Pharmaceuticals Inc. (MIST)
Muller Lorenz — Chief Commercial Officer
Shares
11,180
Price
$1.93
Total Value
$21.58K
Shares Held After
205,406
% of Holdings
5.2%
Milestone Pharmaceuticals Inc. (MIST)
Hasija Amit — CFO & EVP of Corp. Development
Shares
12,245
Price
$1.93
Total Value
$23.63K
Shares Held After
99,848
% of Holdings
10.9%
Milestone Pharmaceuticals Inc. (MIST)
Oliveto Joseph — Director
Shares
34,523
Price
$1.93
Total Value
$66.63K
Shares Held After
482,744
% of Holdings
6.7%
ZIVO Bioscience, Inc. (ZIVO)
Cornell Alison A — Director
Shares
11,709
Price
$8.54
Total Value
$99.99K
Shares Held After
279,481
% of Holdings
4.2%
ZIVO Bioscience, Inc. (ZIVO)
PAYNE JOHN BERNARD — Director
Shares
11,709
Price
$8.54
Total Value
$99.99K
Shares Held After
19,618
% of Holdings
59.7%
Protagonist Therapeutics, Inc. (PTGX)
PATEL DINESH V PH D — Director
Shares
14,205
Price
$84.05
Total Value
$1.19M
Shares Held After
574,505
% of Holdings
2.4%
Protagonist Therapeutics, Inc. (PTGX)
PATEL DINESH V PH D — Director
Shares
10,685
Price
$84.00
Total Value
$897.54K
Shares Held After
574,505
% of Holdings
1.8%
Protagonist Therapeutics, Inc. (PTGX)
MOLINA ARTURO MD — Chief Medical Officer
Shares
5,000
Price
$82.28
Total Value
$411.40K
Shares Held After
84,115
% of Holdings
5.6%
Showing 51–100 of 1179 transactions (page 2 of 24)